Skip to content
2000
Volume 10, Issue 5
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

5-HT2B receptors have been reported to play an important role at cardiac, intestinal and central levels, as well as in bone marrow formation and growth. In the last decade, 5-HT2B receptors have also gained much attention as new targets in therapeutics, but also as off-targets because their activation along with the inhibition of serotonin transporters plays a significant role in the pathogenesis of 5-HT induced valvulopathy. Taking this into account, the present review focuses on the new therapeutic applications of 5-HT2B receptor ligands as well as on the potential concerns.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/156802610791111524
2010-04-01
2025-10-27
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/156802610791111524
Loading

  • Article Type:
    Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test